Nasdaq: PTGX
Protagonist Therapeutics insiders
The officers, directors and 10% owners of Protagonist Therapeutics, Inc. who hold the most stock, valued at the live PTGX price.
$124.02
PTGX today −$3.1M (−2.47%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their PTGX stock
- $144M
- Market value
- $8.09B
- Held by ranked insiders
- 1.78%
Insiders by value of PTGX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Dinesh V. Patel, Ph.D | President and CEO | 522,968 | $64.9M | 0.80% | 2116th |
| 2 | Suneel Gupta | Chief Development Officer | 267,433 | $33.2M | 0.41% | 3474th |
| 3 | David Y. Liu | Chief R&D Strategy Officer | 167,590 | $20.8M | 0.26% | 5042nd |
| 4 | Arturo Molina, MD | Chief Medical Officer | 81,397 | $10.1M | 0.12% | 8699th |
| 5 | Harold E. Selick | Director | 60,845 | $7.5M | <0.1% | 10796th |
| 6 | Asif Ali | Chief Financial Officer | 59,003 | $7.3M | <0.1% | 11055th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Protagonist Therapeutics; see each profile for the filing.